Pfizer's Covid drug Paxlovid may reduce the risk of developing long Covid, study says

People who took Pfizer's antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn't, the study said.

from Health and Science https://ift.tt/2ELv4rW
https://ift.tt/s8IBcYK
https://ift.tt/g0NUfZv